Cyclic Diguanylate Inversely Regulates Motility and Aggregation in Clostridium difficile

Abstract excerpt

Clostridium difficile-associated disease is increasing in incidence and is costly to treat. Our understanding of how this organism senses its entry into the host and adapts for growth in the large bowel is limited. The small-molecule second messenger cyclic diguanylate (c-di-GMP) has been extensively studied in gram-negative bacteria and has been shown to modulate motility, biofilm formation, and other processes...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Antibiotic Resistance in Bacteria
• Share to Clostridium difficile and Clostridium perfringens research
• Share to Nosocomial Infections in ICU